XBiotech Enrolls Its First Patient in Highly Anticipated Phase III Pivotal Trial of Xilonix

Read about how XBiotech Enrolls Its First Patient in the Highly Anticipated Phase III Pivotal Trial of Xilonix.

http://bionews-tx.com/news/2013/04/25/xbiotech-enrolls-first-patient-in-phase-iii-pivotal-trial-of-xilonixtm/

XBiotech’s Xilonix Cancer Treatment Offers Promising Alternative To Chemotherapy

The Austin, Texas-based XBiotech is looking to revolutionize the way that cancer is treated with Xilonix, an antibody that targets cancer cells without the use of toxins traditionally used in chemotherapy

http://www.swbiosearch.com/2013/02/19/xbiotechs-xilonix-cancer-treatment-offers-promising-alternative-to-chemotherapy/